In contrast, RET protein levels were not significantly altered at 24 h in cells treated with inhibitors targeting the PI3K/AKT pathway (Figure 3D), suggesting that oncogenic signaling through the RAS/MAPK pathway is important to maintain RET levels in NB cells in agreement with previous findings [37,49]. The gene discussed is RET; the disease is neuroblastoma.